Cargando…
Public support for neonatal screening for Pompe disease, a broad-phenotype condition
BACKGROUND: Neonatal screening for Pompe disease has been introduced in Taiwan and a few U.S. states, while other jurisdictions including some European countries are piloting or considering this screening. First-tier screening flags both classic infantile and late-onset Pompe disease, which challeng...
Autores principales: | Weinreich, Stephanie Shifra, Rigter, Tessel, van El, Carla Geertruida, Dondorp, Wybo Jan, Kostense, Pieter Johannes, van der Ploeg, Ans T, Reuser, Arnold JJ, Cornel, Martina Cornelia, Hagemans, Marloes Louise Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351372/ https://www.ncbi.nlm.nih.gov/pubmed/22413814 http://dx.doi.org/10.1186/1750-1172-7-15 |
Ejemplares similares
-
Newborn screening for pompe disease? a qualitative study exploring professional views
por: van El, Carla G, et al.
Publicado: (2014) -
Impact of enzyme replacement therapy on survival in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013) -
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
por: Güngör, Deniz, et al.
Publicado: (2011) -
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
por: Güngör, Deniz, et al.
Publicado: (2013) -
Enzyme replacement therapy and fatigue in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)